Related Experiment Video

Updated: Jun 23, 2026

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

Impact of restenosis 10 years after coronary angioplasty

C Espinola-Klein1, H J Rupprecht, R Erbel

  • 1Second Medical Clinic, Johannes Gutenberg Unviersity, Mainz, Germany.

European Heart Journal
|August 26, 1998
PubMed

Insights

Restenosis after percutaneous transluminal coronary angioplasty (PTCA) significantly worsens long-term outcomes. Patients with restenosis faced higher risks of death, bypass surgery, and repeat PTCA, underscoring the need for effective management strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
  • Restenosis, the re-narrowing of the artery after PTCA, is a known complication that can affect long-term outcomes.
  • Understanding the long-term impact of restenosis is crucial for patient management and treatment planning.

Purpose of the Study:

  • To compare the 10-year follow-up results of patients who developed restenosis versus those who did not after single-vessel PTCA.
  • To identify the long-term clinical events associated with restenosis following successful PTCA.
  • To evaluate restenosis as an independent risk factor for adverse cardiovascular events.

Main Methods:

  • A cohort of 313 patients with successful single-vessel PTCA underwent a control angiography at 6 months.
  • Patients were categorized into two groups: those with and without restenosis (defined as >50% diameter stenosis).
  • A 10-year follow-up assessed events including death, myocardial infarction, bypass surgery, and repeat PTCA, analyzed using Fisher's test, logistic regression, and life-table analysis.

Main Results:

  • Restenosis occurred in 28% of patients (87 out of 313).
  • Patients with restenosis showed a significantly higher rate of death (13% vs 5%), bypass surgery (29% vs 8%), and repeat PTCA (63% vs 15%) over 10 years.
  • Logistic regression identified restenosis as an independent predictor, increasing the risk of death 2.8-fold, bypass surgery 5.6-fold, and repeat PTCA 10-fold.

Conclusions:

  • Patients with restenosis following single-vessel PTCA have a significantly poorer 10-year long-term outcome compared to those without restenosis.
  • Despite interventions like repeat PTCA, the survival rate without serious adverse events was substantially lower in the restenosis group (59% vs 83%).
  • Restenosis is a critical independent risk factor for adverse cardiovascular events after PTCA, necessitating further research into preventative and therapeutic strategies.
Abstract

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...